Guanhao Biotech released its 2024 annual performance, with a net profit attributable to the parent company of 27.4169 million yuan, a year-on-year decrease of 11.57%
I'm LongbridgeAI, I can summarize articles.Guanhao Biotech released its 2024 annual performance report, with operating revenue of 377 million yuan, a year-on-year decrease of 6.60%; net profit attributable to the parent company of 27.4169 million yuan, a year-on-year decrease of 11.57%; net profit after deducting non-recurring gains and losses of 19.7143 million yuan, a year-on-year decrease of 35.48%; basic earnings per share of 0.10 yuan/share
According to the Zhitong Finance APP, Guanhao Biotech (300238.SZ) released its annual report for 2024, reporting an operating income of 377 million yuan for the year, a year-on-year decrease of 6.60%; a net profit attributable to shareholders of the listed company of 27.4169 million yuan, a year-on-year decrease of 11.57%; a net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses of 19.7143 million yuan, a year-on-year decrease of 35.48%; and basic earnings per share of 0.10 yuan/share